pfizer oral glp 1 Pfizer, Novo Nordisk bidding war is just the latest escalation of a lucrative GLP-1 race Pfizer's once-daily oral GLP-1 drug

Mitochondrial dysfunction in Parkinsons disease - a key disease hallmark with therapeutic potential

Structure-based design of a hyperthermostable AgUricase for hyperuricemia and gout therapy

GLP-1 therapy involves medications that mimic the glucagon-like peptide-1 hormone, which helps regulate appetite and blood sugar levels

These licensed medications have extensive clinical trial evidence demonstrating safety and efficacy

Survey Data Show People Are Already Using These Peptides Hones survey confirms that the peptides on the FDAs agenda are already part of many Americans wellness routines, despite the lack of a clear prescription pathway